Related Experiment Video
Updated: Aug 5, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Integrating AI in Cardiovascular Systems: Innovations in Diagnosis, Risk Prediction, and Management
Srushti Bhupesh Patil1, Yash Pramod Patil1, Kunal Sharad Patil1
1School of Pharmaceutical Sciences, Sandip University, Nasik, Maharashtra, India.
Abstract:
Worldwide, cardiovascular diseases remain the leading contributors to illness and death, which hinders rapid diagnosis and efficient treatment. Recent developments in artificial intelligence (AI) have transformed cardiovascular medicine by enabling the integration and analysis of large and complex data sets from portable sensors, electronic health records, and medical images. AI algorithms, such as machine learning and deep learning models, excel in detecting detailed patterns and forecasting disease progression, improving risk assessment and diagnostic accuracy. These technologies enable the early diagnosis of disorders such as heart failure, arrhythmias, and coronary artery disease, resulting in more personalized treatment approaches and better patient outcomes. Automated image processing reduces human error and simplifies procedures, while continuous cardiac function can be monitored remotely. As AI systems advance further, they have the potential to revolutionize clinical decision-making by providing real-time information and predictive analyses that anticipate adverse cardiac events. Despite ongoing challenges with data quality, model transparency, and ethical considerations, the use of AI in cardiovascular care is expected to optimize resource allocation, reduce healthcare costs, and ultimately improve survival rates. Adopting this cutting-edge technology represents a crucial step toward a more precise, proactive, and patient-centered strategy with significant potential.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...